Bivictrix Therapeutics plc (BVX) — Delisted · Historical data & RNS archive

Going concern: Material uncertainty

No recent announcements

Annual Report and Accounts (to 2025-12-31)

Michael Kauffman, M.D., Ph.DNon-Executive Chairman

–

Tiffany Jane ThornFounder & Chief Executive Officer

5 yrs 3 mos

Petter Veiby, Ph.DNon-Executive Director

–

Dr Michael Glen KauffmanDirector

4 yrs 8 mos

Alison Lindsay HalsallSecretary

2 yrs 11 mos

BiVictriX is a biotech firm that is quickly gaining ground by utilizing a unique method to create cancer treatments that are both safer and more efficient.

Industry: Health Care
Sector: Health Care
LEI: 213800ZIS5IZNA6N3L53
Region: Europe
Admission date: 11 Aug 2021
Website: bivictrix.com
X: @BiVictriX

Shares in issueas at 31 Aug 2023: 82,526,088
Total Voting Rights: 82,526,088

Going concern: Material uncertainty

No recent announcements

Annual Report and Accounts (to 2025-12-31)

Michael Kauffman, M.D., Ph.DNon-Executive Chairman

–

Tiffany Jane ThornFounder & Chief Executive Officer

5 yrs 3 mos

Petter Veiby, Ph.DNon-Executive Director

–

Dr Michael Glen KauffmanDirector

4 yrs 8 mos

Alison Lindsay HalsallSecretary

2 yrs 11 mos

BiVictriX is a biotech firm that is quickly gaining ground by utilizing a unique method to create cancer treatments that are both safer and more efficient.

Industry: Health Care
Sector: Health Care
LEI: 213800ZIS5IZNA6N3L53
Region: Europe
Admission date: 11 Aug 2021
Website: bivictrix.com
X: @BiVictriX

Shares in issueas at 31 Aug 2023: 82,526,088
Total Voting Rights: 82,526,088

Latest year: FY25
Dividend: No dividend declared

ISIN: GB00BNXH3K91
Exchange: —
Market: Aim

Latest year: FY25
Dividend: No dividend declared

ISIN: GB00BNXH3K91
Exchange: —
Market: Aim

Bivictrix Therapeutics plc

Bivictrix Therapeutics plc

Financial Health

Recent RNS announcements

Annual Reports

Directors (6)

Company details

Shares details